TARSUS PHARMACEUTICALS INC (TARS) Top Institutional Shareholders
TARSUS PHARMACEUTICALS INC (TARS) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended March 31, 2026. The institutional investors covered on this page collectively reported approximately $3.08B in TARS holdings during the latest filing period.
Deep Track Capital, Lp is currently the largest disclosed institutional shareholder of TARS tracked by InsiderSet, reporting ownership valued at approximately $252.54M in its March 31, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $225.18M, representing an estimated loss of -10.83% since the filing period.
The top 10 institutional shareholders tracked on this page collectively account for approximately 53% of the total disclosed TARS value among the investors covered in this analysis. Major shareholders include Deep Track Capital, Lp, Blackrock, Inc., Rtw Investments, Lp, and several other long-term asset managers with concentrated positions in TARSUS PHARMACEUTICALS INC (TARS).
This page ranks the largest institutional TARS shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
Institutional Holders
250
Total Reported Value
$3.08B
Largest Holder
Deep Track Capital, Lp
Largest Position
$252.54M
Insider Transactions (90d)
0
Latest Filing Quarter
Q1 2026
New Institutional Positions
127
Funds Exiting Positions
0
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Deep Track Capital, Lp | 5.21% | 3,600,000 | $252,540,000 | $225,180,000 | -$27,360,000 | -10.83% | |
| Blackrock, Inc. | 0.00% | 3,552,612 | $249,215,733 | $222,215,881 | -$26,999,852 | -10.83% | |
| Rtw Investments, Lp | 2.34% | 3,346,025 | $234,723,654 | $209,293,864 | -$25,429,790 | -10.83% | |
| Paradigm Biocapital Advisors Lp | 3.67% | 2,562,154 | $179,735,103 | $160,262,733 | -$19,472,370 | -10.83% | |
| Janus Henderson Group Plc | 0.08% | 2,240,963 | $157,222,823 | $140,172,236 | -$17,050,587 | -10.84% | |
| Morgan Stanley | 0.01% | 1,944,272 | $136,390,741 | $121,614,214 | -$14,776,527 | -10.83% | |
| Vanguard Capital Management Llc | 0.00% | 1,760,541 | $123,501,951 | $110,121,840 | -$13,380,111 | -10.83% | |
| Jennison Associates Llc | 0.08% | 1,712,124 | $120,105,500 | $107,093,356 | -$13,012,144 | -10.83% | |
| Assenagon Asset Management S.A. | 0.14% | 1,280,194 | $89,805,609 | $80,076,135 | -$9,729,474 | -10.83% | |
| Bank Of America Corp | 0.01% | 1,194,377 | $83,785,547 | $74,708,281 | -$9,077,266 | -10.83% | |
| Tang Capital Management Llc | 4.23% | 1,188,624 | $83,381,974 | $74,348,431 | -$9,033,543 | -10.83% | |
| Geode Capital Management, Llc | 0.00% | 1,121,091 | $78,658,404 | $70,124,242 | -$8,534,162 | -10.85% | |
| State Street Corp | 0.00% | 978,212 | $68,621,572 | $61,187,161 | -$7,434,411 | -10.83% | |
| Driehaus Capital Management Llc | 0.48% | 926,125 | $64,967,669 | $57,929,119 | -$7,038,550 | -10.83% | |
| D. E. Shaw & Co., Inc. | 0.04% | 791,146 | $55,498,892 | $49,486,182 | -$6,012,710 | -10.83% | |
| Invesco Ltd. | 0.01% | 742,497 | $52,086,165 | $46,443,187 | -$5,642,978 | -10.83% | |
| Fmr Llc | 0.00% | 733,334 | $51,443,395 | $45,870,042 | -$5,573,353 | -10.83% | |
| Frazier Life Sciences Management, L.P. | 1.32% | 728,644 | $51,114,377 | $45,576,682 | -$5,537,695 | -10.83% | |
| Millennium Management Llc | 0.03% | 564,579 | $39,605,217 | $35,314,416 | -$4,290,801 | -10.83% | |
| Clearbridge Investments, Llc | 0.03% | 545,351 | $38,256,396 | $34,111,705 | -$4,144,691 | -10.83% | |
| Toronto Dominion Bank | 0.07% | 510,253 | $35,794,248 | $31,916,325 | -$3,877,923 | -10.83% | |
| Nomura Asset Management International Inc. | 0.06% | 499,853 | $35,065,000 | $31,265,805 | -$3,799,195 | -10.83% | |
| Goldman Sachs Group Inc | 0.00% | 439,626 | $30,839,764 | $27,498,606 | -$3,341,158 | -10.83% | |
| Loomis Sayles & Co L P | 0.04% | 407,836 | $28,609,695 | $25,510,142 | -$3,099,553 | -10.83% | |
| Timessquare Capital Management, Llc | 0.46% | 388,590 | $27,259,589 | $24,306,305 | -$2,953,285 | -10.83% | |
| Northern Trust Corp | 0.00% | 352,957 | $24,759,934 | $22,077,460 | -$2,682,474 | -10.83% | |
| Vanguard Portfolio Management Llc | 0.00% | 335,889 | $23,562,613 | $21,009,857 | -$2,552,756 | -10.83% | |
| Franklin Resources Inc | 0.01% | 333,676 | $23,407,371 | $20,871,434 | -$2,535,937 | -10.83% | |
| Ensign Peak Advisors, Inc | 0.04% | 332,982 | $23,358,687 | $20,828,024 | -$2,530,663 | -10.83% | |
| Mpm Bioimpact Llc | 1.79% | 329,750 | $23,131,963 | $20,625,863 | -$2,506,101 | -10.83% | |
| Charles Schwab Investment Management Inc | 0.00% | 328,162 | $23,020,564 | $20,526,533 | -$2,494,031 | -10.83% | |
| Qube Research & Technologies Ltd | 0.03% | 324,014 | $22,729,582 | $20,267,076 | -$2,462,506 | -10.83% | |
| Nuveen, Llc | 0.01% | 315,290 | $22,117,594 | $19,721,390 | -$2,396,205 | -10.83% | |
| Artisan Partners Limited Partnership | 0.04% | 307,307 | $21,557,586 | $19,222,053 | -$2,335,533 | -10.83% | |
| Bnp Paribas Financial Markets | 0.01% | 303,509 | $21,291,156 | $18,984,488 | -$2,306,668 | -10.83% | |
| Vanguard Fiduciary Trust Co | 0.00% | 272,743 | $19,132,921 | $17,060,075 | -$2,072,846 | -10.83% | |
| Braidwell Lp | 0.62% | 265,715 | $18,639,907 | $16,620,473 | -$2,019,434 | -10.83% | |
| Tri Locum Partners Lp | 2.49% | 252,588 | $17,719,048 | $15,799,379 | -$1,919,669 | -10.83% | |
| Squarepoint Ops Llc | 0.04% | 241,033 | $16,908,465 | $15,076,614 | -$1,831,851 | -10.83% | |
| Point72 Asset Management, L.P. | 0.03% | 226,251 | $15,871,508 | $14,152,000 | -$1,719,508 | -10.83% | |
| Rock Springs Capital Management Lp | 0.93% | 225,179 | $15,796,307 | $14,084,946 | -$1,711,361 | -10.83% | |
| Cormorant Asset Management, Lp | 0.80% | 225,000 | $15,783,750 | $14,073,750 | -$1,710,000 | -10.83% | |
| Integral Health Asset Management, Llc | 0.74% | 200,000 | $14,030,000 | $12,510,000 | -$1,520,000 | -10.83% | |
| Vestal Point Capital, Lp | 0.39% | 200,000 | $14,030,000 | $12,510,000 | -$1,520,000 | -10.83% | |
| M&G Plc | 0.06% | 166,364 | $11,645,480 | $10,406,068 | -$1,239,412 | -10.64% | |
| Citadel Advisors Llc | 0.01% | 163,997 | $11,504,389 | $10,258,012 | -$1,246,377 | -10.83% | |
| Canada Pension Plan Investment Board | 0.01% | 152,200 | $10,676,830 | $9,520,110 | -$1,156,720 | -10.83% | |
| Russell Investments Group, Ltd. | 0.01% | 145,926 | $10,236,744 | $9,127,671 | -$1,109,073 | -10.83% | |
| Allspring Global Investments Holdings, Llc | 0.02% | 131,612 | $9,241,795 | $8,232,331 | -$1,009,464 | -10.92% | |
| First Trust Advisors Lp | 0.01% | 122,911 | $8,622,206 | $7,688,083 | -$934,123 | -10.83% |
Frequently asked questions about TARS
Who owns the most TARS stock?
The largest holders of TARS are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for TARSUS PHARMACEUTICALS INC (TARS).
Is TARS widely held by superinvestors?
Many widely followed stocks like TARS appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly TARS is represented among the institutional managers we track.
What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?
Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.